Skip to main content

Bahrain approves Chinese COVID-19 vaccine for front-line workers

The experimental vaccine is currently in phase III clinical trials.
A picture shows the Manama's repurposed convention centre, in which 6,000 people are participating in a large-scale trial of a Chinese-sponsored vaccine for the Covid-19 coronavirus, on August 27, 2020 in the Bahraini capital. - Chinese drug giant Sinopharm began testing the inactivated COVID-19 jab in Bahrain earlier this month after starting a similar trial on 15,000 subjects in the nearby United Arab Emirates in July. The current phase of the study, in which the vaccine's efficacy and safety is tested in

Bahrain’s Health Ministry has approved a coronavirus vaccine for emergency use on front-line health workers, the state news agency BNA reported Tuesday. 

"The results of Phase I and Phase II clinical trials showed the vaccine is safe and effective," Bahrain's Health Minister Faeqa bint Saeed Al Saleh said on Tuesday, according to Reuters. 

The vaccine was developed by Chinese state-owned drugmaker Sinopharm in partnership with Abu Dhabi-based technology company Group 42. According to the researchers, 100% of the volunteers in the clinical trials generated antibodies after two doses. 

Phase III trials are currently underway in Bahrain, which has so far reported 322 deaths from the virus and some 82,000 infections. The United Arab Emirates, Egypt and Jordan are also conducting human trials, and the researchers have said a safe and effective vaccine candidate could be ready for market use by the end of 2020 or early 2021. 

Health officials in Bahrain are also increasing testing availability, and Bahrain’s Health Ministry announced on Tuesday that pharmacies across the kingdom would begin carrying a rapid antigen test that delivers COVID-19 test results within 15 minutes.  

In September, the UAE’s Ministry of Health approved using the China-produced vaccine on high-risk front-line workers. The Gulf country is also taking part in clinical trials for Russia’s so-called Sputnik-V vaccine. 

On Tuesday, Dubai ruler Sheikh Mohammed bin Rashid Al-Maktoum tweeted that he had received an experimental vaccine, without specifying which one. 

“We wish everyone safety and great health, and we are proud of our teams who have worked relentlessly to make the vaccine available in the UAE,” he wrote. “The future will always be better in the UAE.”

Also this week, Israel began human trials for its own coronavirus vaccine. On Sunday, two volunteers received doses of the vaccine, which scientists hope will be ready to roll out to the public by next summer. 

Join hundreds of Middle East professionals with Al-Monitor PRO.

Business and policy professionals use PRO to monitor the regional economy and improve their reports, memos and presentations. Try it for free and cancel anytime.


The Middle East's Best Newsletters

Join over 50,000 readers who access our journalists dedicated newsletters, covering the top political, security, business and tech issues across the region each week.
Delivered straight to your inbox.


What's included:
Our Expertise

Free newsletters available:

  • The Takeaway & Week in Review
  • Middle East Minute (AM)
  • Daily Briefing (PM)
  • Business & Tech Briefing
  • Security Briefing
  • Gulf Briefing
  • Israel Briefing
  • Palestine Briefing
  • Turkey Briefing
  • Iraq Briefing

Premium Membership

Join the Middle East's most notable experts for premium memos, trend reports, live video Q&A, and intimate in-person events, each detailing exclusive insights on business and geopolitical trends shaping the region.

$25.00 / month
billed annually

Become Member Start with 1-week free trial

We also offer team plans. Please send an email to and we'll onboard your team.

What's included:
Our Expertise AI-driven

Memos - premium analytical writing: actionable insights on markets and geopolitics.

Live Video Q&A - Hear from our top journalists and regional experts.

Special Events - Intimate in-person events with business & political VIPs.

Trend Reports - Deep dive analysis on market updates.

All premium Industry Newsletters - Monitor the Middle East's most important industries. Prioritize your target industries for weekly review:

  • Capital Markets & Private Equity
  • Venture Capital & Startups
  • Green Energy
  • Supply Chain
  • Sustainable Development
  • Leading Edge Technology
  • Oil & Gas
  • Real Estate & Construction
  • Banking

Start your PRO membership today.

Join the Middle East's top business and policy professionals to access exclusive PRO insights today.

Join Al-Monitor PRO Start with 1-week free trial